Cleerly Health focuses on improving the diagnosis and treatment of heart disease through its digital healthcare platform. The company utilizes artificial intelligence to analyze coronary computed tomography angiography (CCTA) imaging, which helps clinicians detect atherosclerosis, a condition characterized by plaque buildup in the arteries, at an earlier stage. Cleerly's platform converts complex imaging data into clear insights, allowing healthcare providers to create personalized treatment plans for their patients. This approach enhances the evaluation of heart disease by providing detailed analysis of plaque types, enabling more accurate risk assessments for heart attacks. Unlike traditional methods, Cleerly's technology offers a more comprehensive understanding of cardiovascular health. The goal of Cleerly Health is to improve patient outcomes and financial performance for healthcare providers by delivering effective cardiovascular care management solutions.